Cargando…
S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428442/ http://dx.doi.org/10.1097/01.HS9.0000967452.29390.a8 |
| _version_ | 1785090470300352512 |
|---|---|
| author | Rücker, Frank G Bullinger, Lars Cocciardi, Sibylle Skambraks, Sabrina Luck, Tamara J Weber, Daniela Schneider, Isabelle Corbacioglu, Andrea Gaidzik, Verena I Jahn, Ekaterina Jahn, Nikolaus Kapp-Schwoerer, Silke Schrade, Anika Theis, Frauke Fiedler, Walter Salih, Helmut R Wulf, Gerald Salwender, Hans Schroeder, Thomas Götze, Katharina S Kindler, Thomas Lübbert, Michael Schlenk, Richard F Thol, Felicitas Heuser, Michael Ganser, Arnold Döhner, Hartmut Döhner, Konstanze |
| author_facet | Rücker, Frank G Bullinger, Lars Cocciardi, Sibylle Skambraks, Sabrina Luck, Tamara J Weber, Daniela Schneider, Isabelle Corbacioglu, Andrea Gaidzik, Verena I Jahn, Ekaterina Jahn, Nikolaus Kapp-Schwoerer, Silke Schrade, Anika Theis, Frauke Fiedler, Walter Salih, Helmut R Wulf, Gerald Salwender, Hans Schroeder, Thomas Götze, Katharina S Kindler, Thomas Lübbert, Michael Schlenk, Richard F Thol, Felicitas Heuser, Michael Ganser, Arnold Döhner, Hartmut Döhner, Konstanze |
| author_sort | Rücker, Frank G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428442 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284422023-08-17 S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN Rücker, Frank G Bullinger, Lars Cocciardi, Sibylle Skambraks, Sabrina Luck, Tamara J Weber, Daniela Schneider, Isabelle Corbacioglu, Andrea Gaidzik, Verena I Jahn, Ekaterina Jahn, Nikolaus Kapp-Schwoerer, Silke Schrade, Anika Theis, Frauke Fiedler, Walter Salih, Helmut R Wulf, Gerald Salwender, Hans Schroeder, Thomas Götze, Katharina S Kindler, Thomas Lübbert, Michael Schlenk, Richard F Thol, Felicitas Heuser, Michael Ganser, Arnold Döhner, Hartmut Döhner, Konstanze Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428442/ http://dx.doi.org/10.1097/01.HS9.0000967452.29390.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Rücker, Frank G Bullinger, Lars Cocciardi, Sibylle Skambraks, Sabrina Luck, Tamara J Weber, Daniela Schneider, Isabelle Corbacioglu, Andrea Gaidzik, Verena I Jahn, Ekaterina Jahn, Nikolaus Kapp-Schwoerer, Silke Schrade, Anika Theis, Frauke Fiedler, Walter Salih, Helmut R Wulf, Gerald Salwender, Hans Schroeder, Thomas Götze, Katharina S Kindler, Thomas Lübbert, Michael Schlenk, Richard F Thol, Felicitas Heuser, Michael Ganser, Arnold Döhner, Hartmut Döhner, Konstanze S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title | S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title_full | S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title_fullStr | S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title_full_unstemmed | S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title_short | S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN |
| title_sort | s135: next-generation sequencing-based measurable residual disease monitoring in acute myeloid leukemia with flt3 internal tandem duplication treated with intensive chemotherapy plus midostaurin |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428442/ http://dx.doi.org/10.1097/01.HS9.0000967452.29390.a8 |
| work_keys_str_mv | AT ruckerfrankg s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT bullingerlars s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT cocciardisibylle s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT skambrakssabrina s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT lucktamaraj s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT weberdaniela s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT schneiderisabelle s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT corbaciogluandrea s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT gaidzikverenai s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT jahnekaterina s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT jahnnikolaus s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT kappschwoerersilke s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT schradeanika s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT theisfrauke s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT fiedlerwalter s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT salihhelmutr s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT wulfgerald s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT salwenderhans s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT schroederthomas s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT gotzekatharinas s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT kindlerthomas s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT lubbertmichael s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT schlenkrichardf s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT tholfelicitas s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT heusermichael s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT ganserarnold s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT dohnerhartmut s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin AT dohnerkonstanze s135nextgenerationsequencingbasedmeasurableresidualdiseasemonitoringinacutemyeloidleukemiawithflt3internaltandemduplicationtreatedwithintensivechemotherapyplusmidostaurin |